(Stem Cell Reports 6, April 12, 2016, http://dx.doi.org/10.1016/j.stemcr.2016.02.002).The commercial source of GLP-1 antibody was inadvertently omitted in the Supplemental Information of the original paper published online on March 3, 2016. A new Supplemental Information PDF that contains this information in the Supplemental Experimental Procedures section is now available online with this paper. The authors apologize for any inconvenience that this omission may have caused.
Authors: T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp Journal: Mol Metab Date: 2019-09-30 Impact factor: 7.422